切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2015, Vol. 03 ›› Issue (02) : 114 -117. doi: 10.3877/cma.j.issn.2095-655X.2015.02.009

所属专题: 专题评论 文献

临床思维

阿尔茨海默病诊断标准的演变及评价
李伟1, 肖世富1,()   
  1. 1. 200030 上海交通大学医学院附属精神卫生中心老年精神科 阿尔茨海默病诊治中心
  • 收稿日期:2015-04-30 出版日期:2015-05-26
  • 通信作者: 肖世富
  • 基金资助:
    国家临床重点专科建设(2011-873,OMA-MH); 上海市科委重点课题(10411966400)

The developments and changes in the diagnostic criteria for Alzheimer disease

Wei Li1, Shifu Xiao1,()   

  1. 1. Department of Diagnosis and Treatment of Alzheimer Disease Center Mental Health Center of Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
  • Received:2015-04-30 Published:2015-05-26
  • Corresponding author: Shifu Xiao
  • About author:
    Corresponding author: Xiao Shifu, Email:
引用本文:

李伟, 肖世富. 阿尔茨海默病诊断标准的演变及评价[J]. 中华诊断学电子杂志, 2015, 03(02): 114-117.

Wei Li, Shifu Xiao. The developments and changes in the diagnostic criteria for Alzheimer disease[J]. Chinese Journal of Diagnostics(Electronic Edition), 2015, 03(02): 114-117.

阿尔茨海默病(AD)是引起老年痴呆最为常见的疾病,给我国及世界各国造成了严重的社会和经济负担。美国国家神经病及语言障碍和卒中研究所-阿尔茨海默氏病及相关疾病协会率先公布了AD的诊断标准。随着对AD认识的深入及新诊治技术的发展,AD的诊断标准也发生了较大改变,如更加重视对轻度认知功能障碍阶段的识别,以及在诊断标准中纳入生物标志物等,但不同标准之间也存在着较大的差异。因此,本文就AD诊断标准的演变做一综述。

Alzheimer disease(AD) is the most common cause of dementia, and it has caused a huge economic burden to our country and other nations.Therefore, how to carry out an effective prevention and treatment strategy in the early stage of the disease, has become the key of the treatment of AD.In 1984, the National Institute of Neurological and Communicative Disorders and Stroke, and the Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) firstly announced.With the development of our understanding of AD as well as the new technologies coming out, the diagnostic criteria also develope significantly, such as the more emphasis on mild cognitive impairment(MCI) stage and putting the biomarkers into the diagnostic criteria.However, there are significant differences among diverse standards(e.g.IGW, NIA-AA, etc), so we summized this article reviewed the changes of the AD diagnostic criteria, and gave a detail discussion about them.

[1]
Wimo A,Ballard C,Brayne C, et al.Health economic evaluation of treatments for Alzheimer′s disease:impact of new diagnostic criteria[J]. J Intern Med, 2014, 275(3): 304-316.
[2]
Murayama S,Saito Y. Neuropathological diagnostic criteria for Alzheimer′s disease[J]. Neuropathology, 2004, 24(3): 254-260.
[3]
McKhann G,Drachman D,Folstein M, et al.Clinical diagnosis of Alzheimer′s disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer′s Disease[J]. Neurology, 1984, 34(7): 939-944.
[4]
Knopman DS,DeKosky ST,Cummings JL, et al.Practice parameter:diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001, 56(9): 1143-1153.
[5]
Dubois B,Albert ML.Amnestic MCI or prodromal Alzheimer′s disease?[J]. Lancet Neurol, 2004, 3(4): 246-248.
[6]
Jack CJ,Albert MS,Knopman DS, et al.Introduction to the recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s disease[J]. Alzheimers Dement, 2011, 7(3): 257-262.
[7]
Brayne C. A population perspective on the IWG-2 research diagnostic criteria for Alzheimer′s disease[J]. Lancet Neurol, 2014, 13(6): 532-534.
[8]
Varma AR,Snowden JS,Lloyd JJ, et al.Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer′s disease and frontotemporal dementia[J]. J Neurol Neurosurg Psychiatry, 1999, 66(2): 184-188.
[9]
Alladi S,Xuereb J,Bak T, et al.Focal cortical presentations of Alzheimer′s disease[J]. Brain, 2007, 130(Pt 10): 2636-2645.
[10]
Höglund K,Fourier A,Perret-Liaudet A, et al.Alzheimer′s disease-Recent biomarker developments in relation to updated diagnostic criteria[J]. Clin Chim Acta, 2015.
[11]
White L. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study[J]. J Alzheimers Dis, 2009, 18(3): 713-725.
[12]
Dubois B,Feldman HH,Jacova C, et al.Advancing research diagnostic criteria for Alzheimer′s disease: the IWG-2 criteria[J]. Lancet Neurol, 2014, 13(6): 614-629.
[13]
陈双庆,蔡庆,沈玉英, 等. 轻度认知功能损害患者扣带后回谷氨酸多体素氢质子磁共振波谱研究[J/CD]. 中华诊断学电子杂志, 2013, 1(1): 31-34.
[14]
Morris JC,Blennow K,Froelich L, et al.Harmonized diagnostic criteria for Alzheimer′s disease: recommendations[J]. J Intern Med, 2014, 275(3): 204-213.
[15]
李功迎,宋思佳,曹龙飞, 等. 精神障碍诊断与统计手册第5版解读[J/CD]. 中华诊断学电子杂志, 2014, (4): 310-312.
[16]
Höglund K,Fourier A,Perret-Liaudet A, et al.Alzheimer′s disease-Recent biomarker developments in relation to updated diagnostic criteria[J]. Clin Chim Acta, 2015.
[17]
Holmes D. Bruno Dubois: transforming the diagnosis of Alzheimer′s disease[J]. Lancet Neurol, 2014, 13(6): 541.
[18]
Cummings J. Alzheimer′s disease diagnostic criteria:practical applications[J]. Alzheimers Res Ther, 2012, 4(5): 35.
[19]
Reiman EM,McKhann GM,Albert MS, et al.Clinical impact of updated diagnostic and research criteria for Alzheimer′s disease[J]. J Clin Psychiatry, 2011, 72(12): e37.
[20]
Budson AE,Solomon PR.New diagnostic criteria for Alzheimer′s disease and mild cognitive impairment for the practical neurologist[J]. Pract Neurol, 2012, 12(2): 88-96.
[21]
Sarabia-Cobo CM,Pérez V,Hermosilla C, et al.Apathy and Leukoaraiosis in Mild Cognitive Impairment and Alzheimer′s Disease:Multicenter Diagnostic Criteria according to the Latest Studies[J]. Dement Geriatr Cogn Dis Extra, 2014, 4(2): 228-235.
[1] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[2] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[3] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[4] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[5] 谯钰琪, 惠盼, 南岩东. DGKζ的结构功能及研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 117-120.
[6] 李青原, 冯同, 邱雪琴, 李万成. 迷迭香提取物防治肺纤维化研究进展[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 908-911.
[7] 秦富豪, 郑正, 江滨. 间充质干细胞在克罗恩病肛瘘治疗中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 172-177.
[8] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[9] 栾恒钰, 赛晓勇. 创伤后应激障碍的治疗现状及研究进展[J]. 中华神经创伤外科电子杂志, 2023, 09(02): 112-118.
[10] 郭翃江, 符雪彩, 朱妍妍, 严之红, 王丽娜, 纪红. 基于影响因素的老年阿尔茨海默病认知功能障碍预测模型构建及电子化认知康复训练的应用价值[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 156-161.
[11] 黄文鹏, 邱永康, 杨琦, 宋乐乐, 陈钊, 范岩, 康磊. PET相关影像组学在肿瘤预后中的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 104-110.
[12] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
[13] 肖国中, 林宏城. 大便失禁治疗技术的研究进展[J]. 中华临床医师杂志(电子版), 2022, 16(07): 696-700.
[14] 刘天姿, 王宝军. Toll样受体4在阿尔茨海默病中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 404-409.
[15] 夏禹, 刘寒, 朱瑞. 阿尔茨海默病及相关认知障碍疾病与早老素2基因相关性的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 290-293.
阅读次数
全文


摘要